ZA963134B - New form of (E)-3-[6[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid. - Google Patents

New form of (E)-3-[6[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid.

Info

Publication number
ZA963134B
ZA963134B ZA9603134A ZA963134A ZA963134B ZA 963134 B ZA963134 B ZA 963134B ZA 9603134 A ZA9603134 A ZA 9603134A ZA 963134 A ZA963134 A ZA 963134A ZA 963134 B ZA963134 B ZA 963134B
Authority
ZA
South Africa
Prior art keywords
phenylethoxy
dichlorophenyl
pyridinyl
thio
methyl
Prior art date
Application number
ZA9603134A
Other languages
English (en)
Inventor
Victor Witold
Michael Anthony Harris
Richard Keith Anderson
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA963134B publication Critical patent/ZA963134B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9603134A 1995-04-21 1996-04-19 New form of (E)-3-[6[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid. ZA963134B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9508137.8A GB9508137D0 (en) 1995-04-21 1995-04-21 Formulation

Publications (1)

Publication Number Publication Date
ZA963134B true ZA963134B (en) 1997-02-14

Family

ID=10773317

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9603134A ZA963134B (en) 1995-04-21 1996-04-19 New form of (E)-3-[6[[(2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid.

Country Status (23)

Country Link
US (1) US6093828A (pt)
EP (1) EP0821673B1 (pt)
JP (1) JPH11503737A (pt)
KR (1) KR19990007900A (pt)
CN (1) CN1182418A (pt)
AT (1) ATE198883T1 (pt)
AU (1) AU707089B2 (pt)
BR (1) BR9608003A (pt)
CA (1) CA2218322A1 (pt)
CZ (1) CZ333797A3 (pt)
DE (1) DE69611670T2 (pt)
DK (1) DK0821673T3 (pt)
ES (1) ES2154818T3 (pt)
GB (1) GB9508137D0 (pt)
GR (1) GR3035494T3 (pt)
HU (1) HUP9801574A3 (pt)
NO (1) NO309767B1 (pt)
NZ (1) NZ307493A (pt)
PL (1) PL322897A1 (pt)
PT (1) PT821673E (pt)
TR (1) TR199701213T1 (pt)
WO (1) WO1996033174A1 (pt)
ZA (1) ZA963134B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602675D0 (en) * 1996-02-09 1996-04-10 Smithkline Beecham Plc Process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2119467A1 (en) * 1991-09-19 1993-04-01 Pamela Anne Chambers Pyridine compounds for treating leukotriene-related diseases
AU678979B2 (en) * 1992-06-30 1997-06-19 Smithkline Beecham Corporation Process for making phenylthiomethylpyridinylalkenoates
MA22926A1 (fr) * 1992-06-30 1994-04-01 Smithkline Beecham Corp Procede pour la preparation de nouveaux composes.
GB9313145D0 (en) * 1993-06-25 1993-08-11 Smithkline Beecham Plc Process

Also Published As

Publication number Publication date
NO309767B1 (no) 2001-03-26
DE69611670D1 (en) 2001-03-01
TR199701213T1 (pt) 1998-03-21
DK0821673T3 (da) 2001-06-18
CN1182418A (zh) 1998-05-20
AU707089B2 (en) 1999-07-01
DE69611670T2 (de) 2001-08-23
JPH11503737A (ja) 1999-03-30
ES2154818T3 (es) 2001-04-16
HUP9801574A2 (hu) 1998-11-30
BR9608003A (pt) 1999-01-05
US6093828A (en) 2000-07-25
EP0821673B1 (en) 2001-01-24
EP0821673A1 (en) 1998-02-04
GR3035494T3 (en) 2001-05-31
PL322897A1 (en) 1998-03-02
CZ333797A3 (cs) 1999-01-13
PT821673E (pt) 2001-05-31
NZ307493A (en) 1998-07-28
HUP9801574A3 (en) 1998-12-28
KR19990007900A (ko) 1999-01-25
WO1996033174A1 (en) 1996-10-24
CA2218322A1 (en) 1996-10-24
AU5685996A (en) 1996-11-07
NO974840L (no) 1997-10-20
GB9508137D0 (en) 1995-06-07
ATE198883T1 (de) 2001-02-15
NO974840D0 (no) 1997-10-20

Similar Documents

Publication Publication Date Title
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
IS4972A (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
EP0786995A4 (pt)
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
LV10839A (lv) Arstniecibas lidzeklis lipidu un holesterina vielmainas traucejumu profilaksei un arstesanai so traucejumu profilakses un arstesanas panemiens
GR3035494T3 (en) New form of (e)-3- 6- (2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
BR9205255A (pt) Aril aquil esteres de acido 4,5-dihidroxi-9,10-dihidro-9,10-dioxo-2-antraceno carboxilico com atividade terapeutica
GB9423459D0 (en) Silylation process
HK1010152A1 (en) Novel medical use
MX9708089A (es) Compuestos.
AU3868895A (en) Process for the preparation of furosemide
AU5816396A (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
AU4788696A (en) New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
FR2657005B1 (fr) Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
FR2427822A1 (fr) Medicament pour le traitement des maladies circulatoires, a base de 5-methyl-7-dimethylamino-s-triazolo (1,5-a) pyrimidine
UA7134C2 (uk) Спосіб терапевтичної дії на біологічні об'єкти та пристрій для його здійснення
PL322847A1 (en) Condensed b-carbolins
MY103844A (en) New uses of 4-(3-phosphono-2-propenyl)-2-piperazine- carboxylic acid.
DE19681129D2 (de) Verwendung des alpha,alpha-Diphenylessigsäure-4-(N-Methyl-Piperidyl)esters als Spasmoanalgetikum
UA11627A1 (uk) Спосіб отримаhhя модифіковаhого кремhезема